Showing results (331-340 of 622) with videos related to

Sort By:
Pageof 63
JAMA|April 6, 1994
Hepatotoxic effects of tacrine administration in patients with Alzheimer's diseaseP B Watkins, H J Zimmerman, M J Knapp, et al.
Hepatology (Baltimore, Md.)|October 15, 2008
Using controlled clinical trials to learn more about acute drug-induced liver injuryPaul B Watkins, Paul J Seligman, John S Pears, et al.
Journal of Pediatric Surgery|July 1, 1987
Pneumatic dilatation and operative treatment of achalasia in childrenD K Nakayama, N A Shorter, J T Boyle, et al.
Pharmacogenetics|October 1, 1996
Selective expression of CYP3A5 and not CYP3A4 in human bloodS K Janardan, K S Lown, P Schmiedlin-Ren, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1977
Clinical diagnosis with the stable isotope 13C in CO2 breath tests: methodology and fundamental considerationsD A Schoeller, J F Schneider, N W Solomons, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Induction of CYP3A4 by 1 alpha,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptorP Schmiedlin-Ren, K E Thummel, J M Fisher, et al.
Journal of Pharmaceutical Sciences|June 1, 1988
Bile salt binding properties of commonly used gastrointestinal drugs: maalox, carafate, and questranY F Shiau, J P Schenkein, H J Liu, et al.
Clinical Pharmacology and Therapeutics|July 29, 2014
Systems pharmacology modeling predicts delayed presentation and species differences in bile acid-mediated troglitazone hepatotoxicityK Yang, J L Woodhead, P B Watkins, et al.
The Journal of Clinical Investigation|October 1, 1987
Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and manP B Watkins, S A Wrighton, E G Schuetz, et al.
Pageof 63